Study of Stapokibart injection for seasonal allergic rhinitis
Treatments studied
Part of Immune system & allergy clinical trials.
This study tests a new injection called Stapokibart for people with seasonal allergic rhinitis (hay fever triggered by pollen or mold). The goal is to see if it helps control symptoms like sneezing, runny nose, and itchy eyes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your doctor has already decided to prescribe Stapokibart for your seasonal allergies.
- You have not had an allergic reaction to Stapokibart before.
- You are not currently in or planning to join another clinical trial.
- You do not have a blood cancer (like leukemia or lymphoma).
- You are not pregnant (if female).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new nasal spray (PG-011) for adults with moderate-to-severe seasonal allergies (hay fever). It compares the spray to a placebo to see if it reduces nasal symptoms like stuffiness, sneezing, and runny nose.
This study tests a new injectable medication called stapokibart to help teenagers with seasonal allergic rhinitis (hay fever). The goal is to see if this treatment reduces allergy symptoms like sneezing, congestion, and itchy eyes during allergy season.
Stapokibart is a new injection that works on a key pathway involved in allergy symptoms. This study will test if this once-every-two-week shot can help reduce runny nose, sneezing, and itchy eyes in people with allergic rhinitis (hay fever).
This trial tests a new biologic medicine (injection) to see if it can better control seasonal allergy symptoms in teens who haven't had good relief from standard treatments like nasal sprays.
This study tests a new injection medicine called Stapokibart for treating atopic dermatitis (a chronic skin condition causing itching and inflammation). Your doctor has already decided this medicine might help you before you joined the study.
This study tests a new injection called MG-K10 for people with moderate-to-severe seasonal hay fever that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it can reduce your allergy symptoms over the pollen season.
Hear when a new SAR trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.